Verifying…
Home / Drug A–Z / Marcfix Powder for Oral Suspension

Marcfix Powder for Oral Suspension

NAFDAC Reg. No. B4-3825 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Marcfix Powder for Oral Suspension
NAFDAC number
B4-3825
Active ingredient
Cefixime; Clavulanic Acid (Clavulanate Potassium)
Strength
50 mg/5 mL; 31.25 mg/5 mL
Form
Powder for suspension
Pack size
60 mL
Manufacturer
Not listed
Applicant (holder)
Marcson Healthcare Limited
Approved
25 Feb 2021
Status
Inactive View on NAFDAC ↗
Registration valid to
24 Feb 2026
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Marcfix Powder for Oral Suspension is on the NAFDAC register with an active registration (B4-3825). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Marcfix Powder for Oral Suspension

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

Cefixime for oral suspension is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months and older with the following infections: Uncomplicated Urinary Tract Infections (1.1) Otitis Media (1.2) Pharyngitis and Tonsillitis (1.3) Acute Exacerbations of Chronic Bronchitis (1.4) Uncomplicated Gonorrhea (cervical/urethral) (1.5) To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefixime for oral suspension and other antibacterial drugs, cefixime for oral suspension should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. …

How to take it and how often
  • Adults: 400 mg daily
  • Pediatric patients (6 months and older): 8 mg/kg/day
  • Adults The recommended dose of cefixime is 400 mg daily
  • This may be given as a 400 mg tablet or capsule daily or the 400 mg tablet may be split and given as one half tablet every 12 hours
  • For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of 400 mg is recommended
  • The capsule and tablet may be administered without regard to food
  • In the treatment of infections due to Streptococcus pyogenes , a therapeutic dosage of cefixime should be administered for at least 10 days
  • Pediatric Patients (6 months or older) The recommended dose is 8 mg/kg/day of the suspension
  • This may be administered as a single daily dose or may be given in two divided doses, as 4 mg/kg every 12 hours
  • Note: A suggested dose has been determined for each pediatric weight range
  • Refer to Table 1
  • Ensure all orders that specify a dose in milliliters include a concentration, because cefixime for oral suspension is available in three different concentrations (100 mg/5 mL, 200 mg/5 mL, and 500 mg/5 mL)
  • Table 1
  • Suggested doses for
Strengths it comes in

Cefixime is available for oral administration in the following strengths: Powder for oral suspension, when reconstituted, provides either 100 mg/5 mL or 200 mg/5 mL of cefixime as trihydrate. The powder has an off-white to pale yellow color and is strawberry flavored. Oral Suspension: 100 mg/5 mL and 200 mg/5 mL (3)

Children
  • Safety and effectiveness of cefixime
  • Pediatric patients younger than 6 months of age have not been established
  • The incidence of gastrointestinal adverse reactions, including diarrhea and loose stools, in the
  • Pediatric patients receiving the suspension, was comparable to the incidence seen in adult patients receiving tablets
Older adults

Clinical studies did not include sufficient numbers of subjects aged 65 and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. A pharmacokinetic study in the elderly detected differences in pharmacokinetic parameters [see Clinical Pharmacology (12.3) ] . …

While you are taking it
  • Drug Resistance Patients should be counseled that antibacterial drugs, including cefixime, should only be used to treat bacterial infections
  • They do not treat viral infections (e.g., the common cold)
  • When cefixime is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. …
Talk to a doctor first if
  • Cefixime for oral suspension is contraindicated in patients with known allergy to cefixime or other cephalosporins
  • Contraindicated in patients with known allergy to cefixime or other cephalosporins
Medicines it may not mix with

Elevated carbamazepine levels have been reported in postmarketing experience when cefixime is administered concomitantly. (7.1) Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly with warfarin and anticoagulants. (7.2) 7.1 Carbamazepine Elevated carbamazepine levels have been reported in postmarketing experience when cefixime is administered concomitantly. Drug monitoring may be of assistance in detecting alterations in carbamazepine plasma concentrations. 7.2 Warfarin and Anticoagulants Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly. …

Warnings

Hypersensitivity reactions including shock and fatalities have been reported with cefixime. Discontinue use if a reaction occurs. (5.1) Clostridium difficile associated diarrhea: Evaluate if diarrhea occurs. (5.2) 5.1 Hypersensitivity Reactions Anaphylactic/anaphylactoid reactions (including shock and fatalities) have been reported with the use of cefixime. Before therapy with cefixime is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to cephalosporins, penicillins, or other drugs. …

Possible side effects

Most common adverse reactions are gastrointestinal such as diarrhea (16%), nausea (7%), loose stools (6%), abdominal pain (3%), dyspepsia (3%), and vomiting. (6) To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/m edwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The most commonly seen adverse reactions in U.S. …

Pregnancy and breastfeeding

8.1 Pregnancy Risk Summary Available data from published observational studies, case series, and case reports over several decades with cephalosporin use, including cefixime, in pregnant women have not established drug-associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes (see Data) . …

If you take too much

Gastric lavage may be indicated; otherwise, no specific antidote exists. Cefixime is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of cefixime did not differ from the profile seen in patients treated at the recommended doses.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2024-02-14.

Label for cefixime and clavulanic acid (clavulanate potassium), the active ingredient registered with NAFDAC.

Check your pack of Marcfix Powder for Oral Suspension

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC · WHO · U.S. FDA · Health Canada · NLM

About Marcfix Powder for Oral Suspension

What is in Marcfix Powder for Oral Suspension?

Marcfix Powder for Oral Suspension contains Cefixime; Clavulanic Acid (Clavulanate Potassium) (50 mg/5 mL; 31.25 mg/5 mL), as powder for suspension, according to its NAFDAC registration record.

Is Marcfix Powder for Oral Suspension registered with NAFDAC?

Yes. Marcfix Powder for Oral Suspension is listed on the NAFDAC register under registration number B4-3825, and its registration is active as of 28 October 2026.

Has Marcfix Powder for Oral Suspension been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Marcfix Powder for Oral Suspension in our automatically synced alert list.

How can I check that my pack of Marcfix Powder for Oral Suspension is genuine?

Run a free authenticity scan with the NAFDAC number B4-3825, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Marcfix Powder for Oral Suspension?

Follow your prescription or the leaflet in your pack. The official label says: Adults: 400 mg daily (2.1) Pediatric patients (6 months and older): 8 mg/kg/day (2.2) 2.1 Adults The recommended dose of cefixime is 400 mg daily. This may be given as a 400 mg tablet or capsule daily or the 400 mg tablet may be split and given as one half tablet every 12 hours. For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of 40…

What is Marcfix Powder for Oral Suspension used for?

Cefixime for oral suspension is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months and older with the following infections: Uncomplicated Urinary Tract Infections (1.1) Otitis Media (1.2) Pharyngitis and Tonsillitis (1.3) Acute Exacerbations of Chronic Bronchitis (1.4) Uncomplicated Gonorrhea (cervical/urethral) (1.5) To reduce the development (Summarised from the official U.S. FDA label for cefixime and clavulanic acid (clavulanate potassium). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Marcfix Powder for Oral Suspension? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.